Published in Oncogene on January 01, 1994
GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci (2003) 10.89
GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev (2000) 6.54
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A (2004) 5.37
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J (1999) 3.50
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol (1994) 2.01
Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol (2006) 2.00
Myc proteins as therapeutic targets. Oncogene (2010) 1.88
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol (1998) 1.77
Neuroblastoma and MYCN. Cold Spring Harb Perspect Med (2013) 1.75
The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol Cell Biol (2000) 1.71
Therapeutic Targeting of Myc. Genes Cancer (2010) 1.68
The Max network gone mad. Mol Cell Biol (2001) 1.66
What Are the bona fide GSK3 Substrates? Int J Alzheimers Dis (2011) 1.65
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol (1995) 1.59
Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci U S A (1995) 1.58
Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res (2011) 1.54
Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. Cancer Res (2008) 1.51
Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord (2002) 1.50
Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A (2002) 1.49
MYC degradation. Cold Spring Harb Perspect Med (2014) 1.42
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc. J Virol (2007) 1.36
Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J (2002) 1.36
Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol Cell Biol (1999) 1.18
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol (2002) 1.18
Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol (2000) 1.18
Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem (2011) 1.16
A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev (2008) 1.14
Negative control of the Myc protein by the stress-responsive kinase Pak2. Mol Cell Biol (2004) 1.14
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest (2012) 1.09
Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors. BMC Cell Biol (2008) 1.05
Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol Cell Biol (2013) 1.01
Mechanisms of c-myc degradation by nickel compounds and hypoxia. PLoS One (2009) 0.99
Protein phosphatase 2A stabilizes human securin, whose phosphorylated forms are degraded via the SCF ubiquitin ligase. Mol Cell Biol (2006) 0.99
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1. Cancer Res (2011) 0.94
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant. Breast Cancer Res Treat (2008) 0.94
Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Mol Cell Biol (2000) 0.93
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance. Cell Div (2012) 0.93
Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1. J Biol Chem (2008) 0.92
GSK3beta is a negative regulator of the transcriptional coactivator MAML1. Nucleic Acids Res (2009) 0.91
Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts. PLoS One (2010) 0.90
GSK3 as a Sensor Determining Cell Fate in the Brain. Front Mol Neurosci (2012) 0.90
Immortalization of human neural stem cells with the c-myc mutant T58A. PLoS One (2008) 0.89
Integrin signalling and the cellular response to ionizing radiation. J Mol Histol (2004) 0.87
The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.86
Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549. PLoS One (2013) 0.85
A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes. Breast Cancer Res (2014) 0.85
New insights into the mechanisms of embryonic stem cell self-renewal under hypoxia: a multifactorial analysis approach. PLoS One (2012) 0.83
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat Med (2016) 0.80
Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway. Cell Signal (2008) 0.80
Myc proteins in brain tumor development and maintenance. Ups J Med Sci (2012) 0.80
Gain-of-Function Mutations in the Toll-Like Receptor Pathway: TPL2-Mediated ERK1/ERK2 MAPK Activation, a Path to Tumorigenesis in Lymphoid Neoplasms? Front Cell Dev Biol (2016) 0.79
Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex. Exp Mol Med (2008) 0.78
Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus. J Virol (1996) 0.78
Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis. Oncogene (2013) 0.78
Identification of c-MYC SUMOylation by mass spectrometry. PLoS One (2014) 0.77
Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells. Mol Med Rep (2014) 0.76
MYC Deregulation in Primary Human Cancers. Genes (Basel) (2017) 0.75
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma. Clin Cancer Res (2016) 0.75
GSK-3β controls NF-kappaB activity via IKKγ/NEMO. Sci Rep (2016) 0.75
Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis. PLoS One (2015) 0.75
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling. Genes (Basel) (2017) 0.75
MYC Modulation around the CDK2/p27/SKP2 Axis. Genes (Basel) (2017) 0.75
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma. Cancer Cell (2017) 0.75
The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/cyclinD1 Signaling Pathway. Int J Biol Sci (2017) 0.75
The stress-activated protein kinase subfamily of c-Jun kinases. Nature (1994) 11.45
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 8.37
Phosphorylation of c-jun mediated by MAP kinases. Nature (1991) 8.07
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol (1996) 6.88
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J (1998) 6.28
Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (1995) 6.20
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
A matter of life and cell death. Science (1998) 5.33
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature (1995) 5.00
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell (1999) 4.38
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature (1995) 4.14
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J (1994) 3.62
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J (1993) 3.51
Drip breast milk: it's composition, collection and pasteurization. Early Hum Dev (1977) 3.47
Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem (1986) 3.37
A license to kill. Cell (1996) 3.37
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 3.34
Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell (2000) 3.33
Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem (1991) 3.17
PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol (2001) 3.15
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta (1992) 3.02
Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood (2000) 2.95
Apoptosis in development. Nature (2000) 2.95
Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J (1996) 2.93
Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol (1999) 2.91
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett (1992) 2.85
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science (1997) 2.74
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
The stress-activated protein kinase pathways. Cell Mol Life Sci (1999) 2.72
Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol (2000) 2.67
Protein kinase C phosphorylates pp60src at a novel site. Cell (1985) 2.63
Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem (1992) 2.57
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J (1990) 2.57
Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol (1992) 2.54
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J (1985) 2.53
Natural history of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 2.52
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med (2000) 2.51
Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature (1997) 2.46
Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev (2001) 2.36
Imaging features of retroperitoneal and pelvic schwannomas. Clin Radiol (2005) 2.32
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev (1999) 2.31
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int (2003) 2.29
A breakdown of symmetry in the folding transition state of protein L. J Mol Biol (2000) 2.26
The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol (1996) 2.18
Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol (1999) 2.16
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 2.14
Management of metastatic melanoma during pregnancy. BMJ (1998) 2.10
The links between axin and carcinogenesis. J Clin Pathol (2005) 2.07
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol (2001) 2.02
Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini. Mol Cell Biol (1991) 2.00
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene (1994) 1.99
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J (1996) 1.92
Genetic analysis of protein kinase B (AKT) in Drosophila. Curr Biol (1998) 1.85
The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem (1994) 1.84
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol (1993) 1.82
Curcumin is an in vivo inhibitor of angiogenesis. Mol Med (1998) 1.81
Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet (1992) 1.81
Substrate specificity of a multifunctional calmodulin-dependent protein kinase. J Biol Chem (1985) 1.80
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature (1995) 1.79
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta (1984) 1.77
Isolation and characterization of two distinct forms of protein kinase C. J Biol Chem (1987) 1.76
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol (2008) 1.76
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene (1993) 1.73
Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg (2005) 1.71
Aggressive angiomyxoma. A report of four cases occurring in men. Am J Surg Pathol (1992) 1.69
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Action of Myc in vivo - proliferation and apoptosis. Curr Opin Genet Dev (2000) 1.69
The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene (2000) 1.68
Breast diseases: color Doppler US in differential diagnosis. Radiology (1993) 1.67
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol (2005) 1.66
Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res (1989) 1.64
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
c-myc oncogene expression in colorectal cancer. Cancer (1987) 1.60
Identification of multifunctional ATP-citrate lyase kinase as the alpha-isoform of glycogen synthase kinase-3. Biochem J (1992) 1.60
Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Infect Dis (1997) 1.57
Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development (1999) 1.56
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene (1990) 1.56
Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology (1997) 1.55
Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol (2001) 1.54
Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol (1998) 1.53
Regulation of Drosophila tracheal system development by protein kinase B. Dev Cell (2001) 1.53
Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1. J Biol Chem (2000) 1.53
Gastric carcinoma presenting with testicular metastasis. Br J Urol (1994) 1.52
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol (2001) 1.52
Nipple confusion--who is confused? J Pediatr (1996) 1.50
Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol (2009) 1.50
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiother Oncol (2001) 1.49